Apyx Medical Corporation
US ˙ NasdaqGS ˙ US03837C1062

SecurityAPYX / Apyx Medical Corporation
InstitutionRoyce Micro-cap Trust, Inc /md/
Latest Disclosed Ownership207,527 shares
Latest Disclosed Value $ 466,935
Royce Micro-cap Trust, Inc /md/ reports 479.68% increase in ownership of APYX / Apyx Medical Corporation

On August 15, 2025 - Royce Micro-cap Trust, Inc /md/ filed a NPORT-P form disclosing ownership of 207,527 shares of Apyx Medical Corporation (US:APYX) valued at $466,936 USD as of June 30, 2025. The entity filed a previous NPORT-P on November 17, 2022 disclosing 35,800 shares of Apyx Medical Corporation. This represents a change in shares of 479.68% during the quarter. The current value of the position is $927,646 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-15 2025-06-30 NP Apyx Medical EC US03837C1062 207,527 171,727 479.68 467 191.25 0.0841
2022-11-17 2022-09-30 NP Apyx Medical EC US03837C1062 35,800 0 0.00 161 -23.44 0.0381
2022-08-16 2022-06-30 NP Apyx Medical EC US03837C1062 35,800 0 0.00 210 -10.30 0.0480
2022-05-16 2022-03-31 NP Apyx Medical EC US03837C1062 35,800 0 0.00 234 -49.13 0.0433
2022-02-24 2021-12-31 NP Apyx Medical EC US03837C1062 35,800 0 0.00 459 -7.47 0.0777
2021-11-22 2021-09-30 NP Apyx Medical EC US03837C1062 35,800 0 0.00 496 34.15 0.0854
2021-08-24 2021-06-30 NP Apyx Medical EC US03837C1062 35,800 0 0.00 369 6.96 0.0601
2021-05-17 2021-03-31 NP Apyx Medical EC US03837C1062 35,800 0 0.00 346 34.24 0.0606
2021-02-19 2020-12-31 NP Apyx Medical EC US03837C1062 35,800 0 0.00 258 52.98 0.0500
2020-11-24 2020-09-30 NP Apyx Medical EC US03837C1062 35,800 24,100 205.98 169 162.50 0.0420
2020-08-19 2020-06-30 NP Apyx Medical EC US03837C1062 11,700 0 0.00 65 52.38 0.0176
2020-05-27 2020-03-31 NP Apyx Medical EC US03837C1062 11,700 0 0.00 42 -57.14 0.0149
2020-02-19 2019-12-31 NP Apyx Medical EC 03837C106 11,700 0 0.00 99 24.05 0.0244
2019-11-25 2019-09-30 NP Apyx Medical EC US03837C1062 11,700 11,700 79 0.0212
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.